• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆酸作为α-突触核蛋白聚集的调节剂:对帕金森病治疗的启示。

Bile Acids as Modulators of α-Synuclein Aggregation: Implications for Parkinson's Therapy.

机构信息

Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Knowledge City, Sahibzada Ajit Singh Nagar, Mohali 140306, Punjab, India.

Department of Chemical Sciences, Indian Institute of Science Education and Research, Sector-81, Knowledge City, Sahibzada Ajit Singh Nagar, Mohali 140306, Punjab, India.

出版信息

ACS Chem Neurosci. 2024 Nov 6;15(21):4055-4065. doi: 10.1021/acschemneuro.4c00459. Epub 2024 Oct 15.

DOI:10.1021/acschemneuro.4c00459
PMID:39404233
Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the aggregation of α-synuclein into toxic amyloid fibrils. Recent research suggests that bile acids altered in PD may influence their aggregation. This study investigates the effects of lithocholic acid (LCA) and deoxycholic acid (DCA) on α-synuclein aggregation and toxicity. LCA significantly accelerates aggregation, reducing the lag phase by 75%, while DCA has a milder impact, decreasing the lag phase by 30%. Binding studies show that LCA interacts with the NAC region and DCA with the N-terminal region of α-synuclein. Aggregation assays and electrophoresis reveal that LCA promotes the formation of toxic, SDS-resistant oligomers more effectively than DCA. Cytotoxicity assays confirm a lower cell viability in LCA-treated samples. Additionally, combined LCA and DCA treatment results in enhanced aggregation and toxicity, indicating a synergistic effect. These findings highlight the role of bile acids in α-synuclein aggregation and PD pathogenesis, suggesting that targeting bile acid metabolism could be a therapeutic strategy for PD.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是α-突触核蛋白聚集形成毒性淀粉样纤维。最近的研究表明,PD 中改变的胆汁酸可能会影响其聚集。本研究调查了石胆酸(LCA)和脱氧胆酸(DCA)对α-突触核蛋白聚集和毒性的影响。LCA 显著加速了聚集,将潜伏期缩短了 75%,而 DCA 的影响较小,将潜伏期缩短了 30%。结合研究表明,LCA 与 NAC 区域相互作用,而 DCA 与α-突触核蛋白的 N 端区域相互作用。聚集分析和电泳表明,LCA 比 DCA 更有效地促进了有毒的、不溶于 SDS 的寡聚物的形成。细胞毒性试验证实了 LCA 处理的样品中细胞活力较低。此外,LCA 和 DCA 的联合处理导致聚集和毒性增强,表明存在协同作用。这些发现强调了胆汁酸在α-突触核蛋白聚集和 PD 发病机制中的作用,表明靶向胆汁酸代谢可能是 PD 的一种治疗策略。

相似文献

1
Bile Acids as Modulators of α-Synuclein Aggregation: Implications for Parkinson's Therapy.胆酸作为α-突触核蛋白聚集的调节剂:对帕金森病治疗的启示。
ACS Chem Neurosci. 2024 Nov 6;15(21):4055-4065. doi: 10.1021/acschemneuro.4c00459. Epub 2024 Oct 15.
2
Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.野黄芩苷抑制α-突触核蛋白的未诱导和金属诱导聚集并解聚原纤维:对帕金森病的影响。
Biochem J. 2020 Feb 14;477(3):645-670. doi: 10.1042/BCJ20190705.
3
Identification of Bile Acid-Derived Chemical Chaperone(s) Targeting E46K-Mutated Alpha-Synuclein Protein to Treat Parkinson's Disease: Molecular Modelling, Docking, ADME, and Simulation Studies.鉴定靶向 E46K 突变型 α-突触核蛋白的胆酸衍生化学伴侣治疗帕金森病:分子建模、对接、ADME 和模拟研究。
Appl Biochem Biotechnol. 2024 Apr;196(4):2086-2109. doi: 10.1007/s12010-023-04625-4. Epub 2023 Jul 19.
4
Cytotoxic Oligomers and Fibrils Trapped in a Gel-like State of α-Synuclein Assemblies.聚集态 α-突触核蛋白中被困的细胞毒性寡聚物和原纤维。
Angew Chem Int Ed Engl. 2018 May 4;57(19):5262-5266. doi: 10.1002/anie.201711854. Epub 2018 Apr 14.
5
Polymyxin B accelerates the α-synuclein aggregation.多粘菌素 B 加速α-突触核蛋白聚集。
Biophys Chem. 2021 Oct;277:106628. doi: 10.1016/j.bpc.2021.106628. Epub 2021 Jun 3.
6
Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.定义导致小鼠帕金森病表型的α-突触核蛋白种类。
J Biol Chem. 2019 Jul 5;294(27):10392-10406. doi: 10.1074/jbc.RA119.007743. Epub 2019 May 29.
7
Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability.硫化氢对α-突触核蛋白聚集及细胞活力的影响。
Sci Rep. 2025 May 4;15(1):15597. doi: 10.1038/s41598-025-99794-z.
8
Identification of novel phenolic inhibitors from traditional Chinese medicine against toxic α-synuclein aggregation via regulating phase separation.通过调节相分离从中药中鉴定新型酚类抑制剂以对抗有毒α-突触核蛋白聚集
Int J Biol Macromol. 2025 Mar;297:139875. doi: 10.1016/j.ijbiomac.2025.139875. Epub 2025 Jan 14.
9
Rationally designed peptides inhibit the formation of α-synuclein fibrils and oligomers.合理设计的肽可抑制α-突触核蛋白原纤维和寡聚体的形成。
Eur J Med Chem. 2025 May 5;289:117452. doi: 10.1016/j.ejmech.2025.117452. Epub 2025 Feb 26.
10
A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation.一种靶向 SUMO 相互作用基序的 SUMO1 衍生肽抑制α-突触核蛋白聚集。
Cell Chem Biol. 2021 Feb 18;28(2):180-190.e6. doi: 10.1016/j.chembiol.2020.12.010. Epub 2021 Jan 13.